Skip to main content
. 1998 May;64(5):1694–1699. doi: 10.1128/aem.64.5.1694-1699.1998

TABLE 1.

Chaperone expression plasmids constructed for this studya

Plasmid Promoter (chaperone genes)b Regulatory gene Drug resistancec
pKJE5 trpp (dnaK-dnaJ-grpE) trpR Kmr
pKJE7 araBp (dnaK-dnaJ-grpE) araC Cmr
pKJE8 araBp (dnaK-dnaJ-grpE) araC Kmr
pGro6 trpp (groES-groEL) trpR Kmr
pGro7 araBp (groES-groEL) araC Cmr
pGro11 Pzt-1p (groES-groEL) tetR Cmr
pGro12 araBp (groES-groEL) araC Kmr
pG-KJE2d trpp (dnaK-dnaJ-grpE) trpR Cmr
araBp (groES-groEL) araC
pG-KJE3 araBp (groES-groEL-dnaK-dnaJ-grpE) araC Cmr
pG-KJE6 araBp (dnaK-dnaJ-grpE) araC Cmr
Pzt-1p (groES-groEL) tetR
pG-KJE7 araBp (groES-groEL-dnaK-dnaJ-grpE) araC Kmr
a

All plasmids contained the replication origin of pACYC184 and genes encoding chaperones under control of the promoters indicated. 

b

The chaperone genes (starting with the promoter-proximal gene) controlled by a given promoter are indicated in parentheses. 

c

Kmr, kanamycin resistance; Cmr, chloramphenicol resistance. 

d

The level of dnaK-dnaJ-grpE expression is low for unknown reasons.